Directory

CORBELLA VIRÓS, Xavier

Ext. 5020
Department of Medicine
Grupo de evaluación de determinantes de salud y políticas sanitarias

CORBELLA VIRÓS, Xavier

CV

Teacher profile

Professor Agregat o Titular

Medicine, Faculty of Medicine and Health Sciences. Universitat Internacional de Catalunya

Academic curriculum
  • Doctor en Medicina. Premi Extraordinari de Doctorat i Premi Claustre de Doctors (VI Edició) a la millor Tesi Doctoral de totes les disciplines universitàries del curs 1999/2000 Universitat de Barcelona
  • Especialista en Medicina Interna (MIR) Ministerio de Educación y Ciencia
  • Màster en Direcció d'Institucions Sanitàries Universitat Autònoma de Barcelona
  • Master in Business Administration ESADE Business School
  • Diploma en Finances ESADE Business School
  • Graduated in Medicine Universitat Autònoma de Barcelona
Research interests

Xavier Corbella (Barcelona, 1964) graduated in Medicine from the Autonomous University of Barcelona (1988), is specialist in Internal Medicine (1993), PhD of Medicine (Honors) from the University of Barcelona (2000), and Master in Business Administration (MBA) (Honors) from the ESADE Business School (2005). He is Head of the Medical Department at Football Club Barcelona (2022), Vice Dean of the School of Medicine at Universitat Internacional de Catalunya (2013), where he is Director of the Hestia Chair in Integrated Health and Social Care (2016) and holds a position of Senior Lecturer of Medicine (2019). From 2005 to 2013 he was Medical Director at Althaia-Hospitals (Manresa), CEO at Bellvitge University Hospital, Managing Director of the Southern Metropolitan Health Area of Barcelona, and CEO at Hospital de Sant Pau (Barcelona). From 2013 to 2022 he has been Head of the Internal Medicine Department at Bellvitge University Hospital, and Secretary General of the European Federation of Internal Medicine (elected in Milan 2017, reelected in Lisbon 2019). He has authored 170 indexed publications, 13 book chapters, and more than 150 invited lectures. He has 4 six-year term of research officialy accredited by the National Commission for the Evaluation of Research Activity CNEAI (1995-2000, 2001-2006, 2010-2015, 2016-2021). He has directed 11 doctoral theses and is currently directing other 5.

Publications

Articles
Book chapters
  • Riera-Mestre, A.; Corbella, X., (2019), "Tromboprofilaxis farmacológica en las alternativas a la hospitalización convencional para el paciente médico no oncológico", Thrombosis Medicine, pp. 1-19, Esmon Publicidad SA. ISBN: 10508-2017.
  • Corbella, X.; Contel, Jc., (2012), "Nuevos retos para la enfermería comunitaria en la atención a la cronicidad", Cuidar: Arte y Ciencia, pp. 195-216, UIC Publicacions. ISBN: 978-84-939888-4-5.
  • Ridao, M.; Corbella, X., (2010), "Disseny i desenvolupament de nous models organitzatius dels professionals d'infermeria", Gestió d'Infermeria, pp. 219-228, Documenta Universitaria. ISBN: 978-84-92707-65-2.
  • Ariza, J.; Corbella, X., (2002), "Acinetobacter: Epidemiology and Control", Infection Control in the ICU Environment, pp. 77-92, KLUWER ACADEMIC PUBLISHERS, COP. ISBN: 0-7923-7415-0.
  • Corbella, X., (2001), "An approach to controlling Acinetobacter outbreaks in the ICUs", Infection in Critically Ill: an ongoing challenge, pp. 161-171, Springer-Verlag. ISBN: 88-470-0138-2.
  • Corbella, X., (1999), "Empiema y shock hipovolémico después de vómito intenso", Casos clínicos en Enfermedades Infecciosas, pp. 25-28, Momento Médico Iberoamericana, SL. ISBN: 99MS345-12/99.
  • Corbella, X.; Ariza, J., (1998), "Medidas de Control de un brote epidémico en UCI por Acinetobacter baumannii multirresistente", Acinetobacter baumannii en pacientes críticos, pp. 125-142, Merck Sharp and Dohme, SA.
  • Gudiol, F.; Corbella, X., (1996), "Sepsis de origen desconocido (Cap. 38)", Pautas de actuación en Medicina de Urgencias, pp. 207-208, JM Gómez, R Pujol, R Sabaté (eds.) Ed. Mosby. ISBN: 8481741671.
  • Gudiol, F.; Corbella, X., (1996), "Infección del tracto urinario (Cap. 33)", Pautas de actuación en Medicina de Urgencias, pp. 181-187, JM Gómez, R Pujol, R Sabaté (eds.) Ed. Mosby.
  • Rufí, G.; Corbella, X., (1996), "Gastroenteritis infecciosa aguda (Cap. 32)", Pautas de actuación en Medicina de Urgencias, pp. 177-179, JM Gómez, R Pujol, R Sabaté (eds.) Ed. Mosby.
  • Rufí, G.; Corbella, X., (1996), "Endocarditis infecciosa (Cap. 31)", Pautas de actuación en Medicina de Urgencias, pp. 173-175, JM Gómez, R Pujol, R Sabaté (eds.) Ed. Mosby.
  • Corbella, X.; Gudiol, F., (1993), "Enfermedades producidas por bacilos gram positivos y cocos gram negativos", Manual de Medicina, pp. 1516-1524, MASSON- Salvat. ISBN: 84-458-0093-0.

Projects and research

  • Role of immune system inborn errors as determinants of the COVID-19 severity in hospitalized patients01/01/2022 - 31/12/2024
    IP: Corbella, X.; Lazaro, C.
    Fundació la Marató de TV3
  • Do autoantibodies against type I interferons continue to confer a higher risk of severe COVID-19 in fully vaccinated population?03/01/2022 - 02/01/2023
    IP: Corbella, X.; Solanich, X.
    Institut d'Investigació Biomèdica de Bellvitge
  • Effect of an intensive weight-loss intervention with hypocaloric mediterranean diet, physical activity and behavioral support on primary cardiovascular prevention: PREDIMED-PLUS Trial01/01/2020 - 31/12/2022
    IP: Pinto-Sala, X.
    Ministerio de Ciencia e Innovación. Instituto de Salud Carlos III.
  • Proyecto Coordinado sobre el Abordaje Multinivel de COVID-19 en el ámbito sociosanitario30/11/2021 - 31/05/2022
    IP: Corbella, X.
    Fundación Hestia
  • Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS01/01/2017 - 31/12/2019
    IP: Pintó, X.
    Instituto de Salud Carlos III
  • Screening for Chronic Kidney Disease (CKD) among Older People across Europe (SCOPE)01/05/2015 - 30/04/2019
    IP: Formiga, F.
    European Union’s Horizon 2020 research and innovation programme
  • Riesgo de acidosis láctica asociado al uso de metformina en pacientes diabéticos tipo 2 con enfermedad renal crónica moderada-severa: estudio de casos y controles01/01/2016 - 31/12/2018
    IP: Videla, S.
    Instituto de Salud Carlos III; Fondo de Investigación Sanitaria
  • Epidemiologia de la resistència antibiòtica de l’àrea del Baix Llobregat01/01/1999 - 31/12/2001
    IP: Pallares, R.
    Agència d'Avaluació de Tecnologia i Recerca Mèdica
  • Estudio microbiológico y epidemiológico de las infecciones por Staphylococcus coagulasa-negativo. Sensibilidad antibiótica y caracterización clonal01/01/1999 - 31/12/2000
    IP: Domínguez, MA.
    Instituto de Salud Carlos III; Fondo de Investigación Sanitaria
  • Estudio de la eficacia antibiótica en el modelo de neumonía experimental en el ratón por Acinetobacter baumannii multirresistente01/01/1998 - 31/12/1999
    IP: Ariza, J.
    Instituto de Salud Carlos III; Fondo de Investigación Sanitaria
  • Integrated Health and Social Care01/07/2016 - 30/06/2021
    IP: Corbella, X.
    Fundación Hestia
  • Phase III Multicenter, double-blind, randomized, placebo-controlled, parallel group evaluation of the efficacy, safety, and tolerability of Bococizumab (PF-04950615) in reducing the number of major cardiovascular events in high risk subjects; Numero EudraCT: 2013-002795-41; Número de protocolo B1481038; Código Comité Ético de Investigación Clínica CEIC: AC176/1301/01/2015 - 31/12/2016
    IP: Pinto, X.
    Pfizer Inc.
  • International collaborative project: The REPOSI Registry (REgistro POliterapie SIMI)01/01/2014 - 31/12/2015
    IP: Corbella, X.
    The IRCCS Cà Granda Maggiore Policlinico Hospital Foundation of Milan, and the IRCCS Istituto di Ricerche Farmacologiche Mario Negri of Milan

Activities

  • European Congress of Internal Medicine (Lisbon, Portugal) Ponència convidada "Breaking the walls of the Future Hospital", 2019.
  • American College of Physicians (ACP) Internal Medicine Meeting (Philadelphia, PA, USA) Ponència convidada "Transitions of Care: the European Approach", 2019.
  • European Association of Hospital Managers Congress (Estoril, Portugal) Ponència convidada "Hospital Ambulatory Medicine", 2018.
  • European Congress of Internal Medicine (Wiesbaden, Germany) Ponència convidada "How to stop the obesity tsunami?", 2018.
  • Congresso Nacional de Medicina Interna Ponència convidada "Alternatives to Conventional Hospitalization", 2018.
  • European Congress of Internal Medicine (Wiesbaden, Germany) Ponència convidada "Assessment of value in medicine", 2017.
  • European Congress of Internal Medicine (Moscow, Russian Federation) Ponència convidada "Internists leading “Major Ambulatory Medicine” as an alternative to standard hospitalization: an opportunity and not a loss", 2015.
  • Targeting the burden of Polypharmacy in the elderly International Seminar (Milan, Italy) Ponència convidada "Addressing inpatient admissions and readmissions due to adverse drug reactions in the oldest old", 2015.
  • The Role of Molecular Biology (Mysore, India) Ponència convidada "Outbreaks of Nosocomial Infections due to Multirresistant Bacteria", 2014.
  • Leaping Forward Ponència convidada "Need for more beds or better patient management ?", 2014.